|
시장보고서
상품코드
2050586
신경조절 디바이스 시장 : 디바이스 유형별, 용도별, 최종사용자별, 지역별Neuromodulation Devices Market, By Device Type, By Application, By End User, By Geography |
||||||
신경조절 디바이스 시장은 2026년에 215억 9,000만 달러로 추계되고 있으며, 2033년까지 588억 5,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 15.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 215억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 15.40% | 2033년 시장 규모 예측 : | 588억 5,000만 달러 |
신경 변조 장치는 전기 신호, 약물 또는 다른 형태의 에너지를 사용하여 신경을 자극하고 통증 신호가 뇌에 도달하기 전에 그 전달을 차단하여 통증 완화를 가져옵니다. 뉴로모듈레이션 디바이스는 이식형 의료기기로 전기 자극이나 약물 투여를 통해 일부 만성질환에 대한 치료 솔루션을 제공합니다. 뉴로모듈레이션 장치는 척수자극기, 심부뇌자극기, 미주신경자극기, 천골신경자극기, 위전기자극기 등 5가지 주요 기술로 분류됩니다. 뉴로모듈레이션 장치는 난청, 만성통증, 파킨슨병 등의 질환을 치료하기 위해 신경과 뇌에 전기적 자극을 보내어 신경과 뇌에 자극을 주는 장치입니다. 전기자극은 척수손상이나 신경질환에 따른 근력저하를 치료하기 위해 전기치료를 이용합니다. 이는 전기 자극을 활성화하고 신경 변조 장치의 전극에 신호를 전달하여 탈분극을 일으켜 통증을 완화하고 근력을 향상시키는 특성을 가지고 있습니다. 다양한 유형의 전기 자극 장치가 통증 관리, 비만, 기타 질병을 치료하기 위해 설계되었습니다.
시장 역학
규제 당국의 제품 승인 증가는 예측 기간 중 글로벌 신경 변조 장치 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2023년 4월 19일 의료 기술 기업 바이오트로닉(BIOTRONIK)은 척수 자극(SCS) 시스템 '프로스페라(Prospera)'가 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 이 시스템은 세계 최초의 다상 자극 패러다임인 'RESONANCE'를 특징으로 하며, 자동적이고 객관적인 일일 원격 모니터링, 지속적인 관리 및 지원을 제공하여 예방적 치료를 가능하게 하는 환자 중심 케어 모델 'Embrace One'과 결합되어 있습니다. 결합되어 있습니다. 이번 승인은 바이오트로닉의 새로운 사업 부문인 '바이오트로닉 뉴로(BIOTRONIK Neuro)'의 출범을 의미합니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 매출 창출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서에서는 글로벌 신경조절 장치 시장의 주요 기업 개요을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등의 정보를 바탕으로 정리하여 전해드립니다.
- 본 조사에서 다루어지고 있는 주요 기업에는 Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., Synapse Biomedical Inc.가 포함됩니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 도와줄 것입니다.
- 이 세계의 신경조절 장치 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 신경조절장치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 신경조절 디바이스 시장 : 디바이스 유형별, 2021-2033년
제5장 세계의 신경조절 디바이스 시장 : 용도별, 2021-2033년
제6장 세계의 신경조절 디바이스 시장 : 최종사용자별, 2021-2033년
제7장 세계의 신경조절 디바이스 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.06.10Neuromodulation Devices Market is estimated to be valued at USD 21.59 Bn in 2026 and is expected to reach USD 58.85 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 21.59 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.40% | 2033 Value Projection: | USD 58.85 Bn |
Neuromodulation devices stimulate nerves with electrical signals, pharmaceutical agents, or other forms of energy neurostimulation that provides pain relief by blocking the transmission of pain signals before they reach the brain. Neuromodulation devices are implantable medical devices, which introduce therapeutic solutions to some chronic diseases through electric stimulation or medication. Neuromodulation devices are segmented into five major technologies, namely: spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices and gastric electric stimulation devices. Neuromodulation devices deliver electrical impulses to the nerves and the brain by treating disorders such as deafness, chronic pain, and Parkinson's disease. Lectrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has a property to activate electrical impulse and transmit signals to the electrodes of neuromodulation device, which causes depolarization and, in turn, reduces pain and improves the muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.
Market Dynamics
Increasing product approvals by regulatory authorities are expected to drive the global neuromodulation devices market growth over the forecast period. For instance, on April 19, 2023, BIOTRONIK, a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for Prospera, a Spinal Cord Stimulation (SCS) system. The system features RESONANCE, the first and multiphase stimulation paradigm, paired with Embrace One, a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support. This approval marks the launch of the company's new business segment, BIOTRONIK Neuro.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neuromodulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
- The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuromodulation devices market
Market Segmentation
- Global Neuromodulation Devices Market, Device Type (Revenue, USD Bn, 2021 - 2033)
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
- Global Neuromodulation Devices Market, Application (Revenue, USD Bn, 2021 - 2033)
- Pain Management
- Neurological and Movement Disorder Management
- Musculoskeletal Disorder Management
- Metabolism and GIT Management
- Others (Incontinence Management, etc.)
- Global Neuromodulation Devices Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Others (Nursing Facilities, etc.)
- Global Neuromodulation Devices Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Global Neuromodulation Devices Market Companies
- Medtronic
- BD
- LivaNova
- Axonics, Inc.
- ShiraTronics
- Abbott
- Bioventus
- Neuronetics
- NEVRO CORP
- Integer Holdings Corporation
- BIOTRONIK
- NeuroPace, Inc.
- NeuroMetrix, Inc.
- Helius Medical Technologies, Inc.
- Synapse Biomedical Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trend Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Guidelines
- Product launches
- Key Development
- PEST Analysis
- PORTER's Analysis
- Regulatory Scenario
- Mergers and Acquisitions
- Manufacturer Revenue
- Healthcare Spending by Country
4. Global Neuromodulation Devices Market, By Device Type, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Spinal Cord Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Deep Brain Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Sacral Nerve Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Vagus Nerve Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Gastric Electric Stimulation Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
5. Global Neuromodulation Devices Market, By Application, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Neurological and Movement Disorder Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Musculoskeletal Disorder Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Metabolism and GIT Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Others (Incontinence Management, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
6. Global Neuromodulation Devices Market, By End User, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Specialized Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Others (Physiotherapy Centers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
7. Global Neuromodulation Devices Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021-2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LivaNova
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Axonics, Inc.
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ShiraTronics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Neuronetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NEVRO CORP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Integer Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BIOTRONIK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NeuroPace, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NeuroMetrix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Helius Medical Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Synapse Biomedical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
